These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 21171815)

  • 1. Diclofenac-loaded Eudragit S100 nanosuspension for ophthalmic delivery.
    Ahuja M; Dhake AS; Sharma SK; Majumdar DK
    J Microencapsul; 2011; 28(1):37-45. PubMed ID: 21171815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eudragit RL 100-based nanoparticulate system of aceclofenac for ocular delivery.
    Katara R; Majumdar DK
    Colloids Surf B Biointerfaces; 2013 Mar; 103():455-62. PubMed ID: 23261566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycerogelatin-based ocular inserts of aceclofenac: physicochemical, drug release studies and efficacy against prostaglandin E₂-induced ocular inflammation.
    Mathurm M; Gilhotra RM
    Drug Deliv; 2011 Jan; 18(1):54-64. PubMed ID: 20718601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design, characterization, and evaluation of aceclofenac-loaded Eudragit RS 100 nanoparticulate system for ocular delivery.
    Katara R; Sachdeva S; Majumdar DK
    Pharm Dev Technol; 2019 Mar; 24(3):368-379. PubMed ID: 29897843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrocortisone nanosuspensions for ophthalmic delivery: A comparative study between microfluidic nanoprecipitation and wet milling.
    Ali HS; York P; Ali AM; Blagden N
    J Control Release; 2011 Jan; 149(2):175-81. PubMed ID: 20946923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Zn-Al-NO(3)-layered double hydroxides with intercalated diclofenac for ocular delivery.
    Cao F; Wang Y; Ping Q; Liao Z
    Int J Pharm; 2011 Feb; 404(1-2):250-6. PubMed ID: 21093561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimizing flurbiprofen-loaded NLC by central composite factorial design for ocular delivery.
    Gonzalez-Mira E; Egea MA; Souto EB; Calpena AC; García ML
    Nanotechnology; 2011 Jan; 22(4):045101. PubMed ID: 21169662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Self assembling nanostructures for sustained ophthalmic drug delivery.
    Khopade AJ; Jain NK
    Pharmazie; 1995 Dec; 50(12):812-4. PubMed ID: 8584558
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulation and evaluation of chitosan microspheres of aceclofenac for colon-targeted drug delivery.
    Umadevi SK; Thiruganesh R; Suresh S; Reddy KB
    Biopharm Drug Dispos; 2010 Oct; 31(7):407-27. PubMed ID: 20848388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
    Maghsoodi M; Sadeghpoor F
    Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development and Evaluation of Diclofenac Sodium Loaded-N-Trimethyl Chitosan Nanoparticles for Ophthalmic Use.
    Asasutjarit R; Theerachayanan T; Kewsuwan P; Veeranodha S; Fuongfuchat A; Ritthidej GC
    AAPS PharmSciTech; 2015 Oct; 16(5):1013-24. PubMed ID: 25609376
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preparation of hydrocortisone nanosuspension through a bottom-up nanoprecipitation technique using microfluidic reactors.
    Ali HS; York P; Blagden N
    Int J Pharm; 2009 Jun; 375(1-2):107-13. PubMed ID: 19481696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chitosan grafted methoxy poly(ethylene glycol)-poly(ε-caprolactone) nanosuspension for ocular delivery of hydrophobic diclofenac.
    Shi S; Zhang Z; Luo Z; Yu J; Liang R; Li X; Chen H
    Sci Rep; 2015 Jun; 5():11337. PubMed ID: 26067670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasonically controlled release and targeted delivery of diclofenac sodium via gelatin magnetic microspheres.
    Saravanan M; Bhaskar K; Maharajan G; Pillai KS
    Int J Pharm; 2004 Sep; 283(1-2):71-82. PubMed ID: 15363503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a novel intraarticular injection of diclofenac for the treatment of arthritis: a preclinical study in the rabbit model.
    Wen X; Huang X; Wu H
    Acta Biochim Pol; 2021 Jan; 68(1):71-76. PubMed ID: 33480230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Preparation of diclofenac sodium liposomes and its ocular pharmacokinetics].
    Sun KX; Wang AP; Huang LJ; Liang RC; Liu K
    Yao Xue Xue Bao; 2006 Nov; 41(11):1094-8. PubMed ID: 17262954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a novel ophthalmic ciclosporin A-loaded nanosuspension using top-down media milling methods.
    Kim JH; Jang SW; Han SD; Hwang HD; Choi HG
    Pharmazie; 2011 Jul; 66(7):491-5. PubMed ID: 21812323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Formulation optimization of double emulsification method for preparation of enzyme-loaded Eudragit S100 microspheres.
    Rawat M; Saraf S
    J Microencapsul; 2009 Jun; 26(4):306-14. PubMed ID: 18686142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diclofenac sodium delivery to the eye: in vitro evaluation of novel solid lipid nanoparticle formulation using human cornea construct.
    Attama AA; Reichl S; Müller-Goymann CC
    Int J Pharm; 2008 May; 355(1-2):307-13. PubMed ID: 18242022
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of diclofenac sodium 0.1% ophthalmic solution in the treatment of ocular symptoms after bilateral radial keratotomy.
    Hettinger ME; Gill DJ; Robin JB; Levy RH; Koester J
    Cornea; 1997 Jul; 16(4):406-13. PubMed ID: 9220237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.